About Beckman Coulter Genomics
Beckman Coulter Genomics is a company based in Danvers (United States) founded in 2008 was acquired by Genewiz in December 2015.. Beckman Coulter Genomics offers products and services including Next Generation Sequencing, Sanger Sequencing, and Gene Synthesis. Beckman Coulter Genomics operates in a competitive market with competitors including Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others.
- Headquarter Danvers, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genewiz Germany Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Beckman Coulter Genomics
Beckman Coulter Genomics offers a comprehensive portfolio of products and services, including Next Generation Sequencing, Sanger Sequencing, and Gene Synthesis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-throughput DNA sequencing for research and clinical use.
Method for accurate DNA sequence verification.
Custom synthesis of genes for biotechnology applications.
Funding Insights of Beckman Coulter Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Beckman Coulter Genomics
Beckman Coulter Genomics has secured backing from 1 investor. Prominent investors backing the company include Genewiz. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Genomic services are provided for the life sciences industry.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Beckman Coulter Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Beckman Coulter Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Beckman Coulter Genomics Comparisons
Competitors of Beckman Coulter Genomics
Beckman Coulter Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| domain | founded_year | HQ Location |
Next-generation gene sequencing and multi-omics technologies are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Beckman Coulter Genomics
When was Beckman Coulter Genomics founded?
Beckman Coulter Genomics was founded in 2008.
Where is Beckman Coulter Genomics located?
Beckman Coulter Genomics is headquartered in Danvers, United States. It is registered at Danvers, Massachusetts, United States.
What does Beckman Coulter Genomics do?
Beckman Coulter Genomics was founded in 2008 in Danvers, United States, within the genomics sector. Sanger DNA sequencing, next-generation sequencing, and qPCR services are offered to aid research, biologics testing, and clinical trials. Compliance with GLP, GMP, and CLIA regulatory guidelines is maintained. Bioinformatics solutions are also delivered to support these operations.
Who are the top competitors of Beckman Coulter Genomics?
Beckman Coulter Genomics's top competitors include Novogene Corporation, Singular Genomics and Source BioScience.
What products or services does Beckman Coulter Genomics offer?
Beckman Coulter Genomics offers Next Generation Sequencing, Sanger Sequencing, and Gene Synthesis.
Who are Beckman Coulter Genomics's investors?
Beckman Coulter Genomics has 1 investor. Key investors include Genewiz.